Vitality Products, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA92847D1050
CAD
0.04
0.01 (33.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Vitality Products, Inc. stock-summary
stock-summary
Vitality Products, Inc.
Pharmaceuticals & Biotechnology
Vitality Products Inc. is a Canada-based company, which is a manufacturer, marketer and distributor of natural health products (NHPs), including vitamins, minerals and nutritional supplements. The Company maintains a distribution facility in Vancouver, British Columbia and an agricultural property in Whatcom County, Washington. The Company offers its products in categories, such as multivitamins, digestion, stress and sleep. It has developed a product line of NHPs. Its products include Vitality Time Release Super Multi+, Vitality Time Release B Complete+C, Vitality Digest+, Vitality Relax+ and VITALITY Power Iron+ Organic Spirulina. All of the Company's products are made locally and are third party tested. The Company's products are available for sale in over 270 retail stores located in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Yukon.
Company Coordinates stock-summary
Company Details
837 West Hastings Street, Suite 304 , VANCOUVER BC : V6C 3N6
stock-summary
Tel: 1 604 68366111 604 6836611
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Bruce McDonald
Independent Chairman of the Board
Mr. W. Douglas Grant
President, Chief Executive Officer, Director
Ms. Cheryl Grant
Chief Financial Officer, Vice President, Secretary, Director
Mr. Colby Fackler
Director
Mr. Richard Gannon
Director
Mr. Brian Gessner
Director
Mr. Stuart Pennington
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Apr 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 1 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.39

stock-summary
Return on Equity

7.65%

stock-summary
Price to Book

-0.96